Screening for reproductive toxicity in Fundulus heteroclitus by genetic expression profiling

Biomarkers

Volumn 1, Issue 2, 1996, Pages 123-135

  Craig, J C ^a   Westerman, M E ^b   Bennett, G D ^a   DiMichele, L ^b   Finnell, R H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Arsenate; Genetic expression profiling; In vitro assay; Sodium valproate; Teratology

Indexed keywords

EID: 8944250305     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.3109/13547509609088680     Document Type: Article

References (55)

1. ARMSTRONG, P. B. and CHILD, J. S. (1965) Stages in the normal development of Fundulus heteroclitus. Biological Bulletin (MBL Publishers, Massachusetts and New York), pp. 143-168.
2. BOHN, M. C. (1980) Granule cell genesis in hippocampus of rats treated with hydrocortisone. Neuroscience, 5(11), 2003-2012.
3. CASAREH, L. J. and DOULL, J. (1980) Toxicology: the Basic Science of Poisons, 2nd edition (Macmillan Publishing Co., Inc., New York).
4. CASAREH, L. J. and DOULL, J. (1996) Toxicology: the Basic Science of Poisons, 5th edition (McGraw-Hill Co., Inc., New York).
5. COPP, A. J., BROOK, F. A., ESTIBEIRO, J. P., SHUM, A. S. W. and COCKROFT, D. L. (1990) The embryonic development of mammalian neural tube defects. Progress in Neurobiology, 5, 363-403.
6. DENCKER, L., NAU, H. and D'ARGY, R. (1990) Marked accumulation of valproic acid in embryonic neuroepithelium of the mouse during early organogenesis. Teratology, 44, 699-706.
7. DEYOUNG, D. J., BANTLE, J. A. and FORT, D. J. (1991) Assessment of the developmental toxicity of ascorbic acid, sodium selenate, coumarin, serotonin, and 13-cis retinoic acid using FETAX. Drug and Chemical Toxicology, 14(1-2), 127-141.
8. DOPPLER, W., GRONER, B. and BALL, R. K. (1989) Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line. Proceedings of the National Academy of Sciences, USA, 86, 104-108.
9. EBERWINE, J. H., YEH H., MIYASHIRO, K., CAO, Y., NAIR, S., FINNELL, R. H., ZETTEL, M. and COLEMAN, P. (1992a) Analysis of gene expression in single live neurons. Proceedings of the National Academy of Sciences, USA, 89, 3010-3014.
10. EBERWINE, J. H., SPENCER, C., MIYASHIRO, K., MACKLER, S. and FINNELL, R. H. (1992b) cDNA synthesis in situ: Methods and applications. In Methods in Enzymology, Vol. 216, G. Wu, ed. (Academic Press, New York), pp. 80-100.
11. FINNELL, R. H. (1991) Genetic differences in susceptibility to anticonvulsant drug induced developmental defects. Pharmacology and Toxicology, 69, 223-227.
12. FINNELL, R. H., BENNETT, G. D., KARRAS, S. B. and MOHL, V. K. (1988) Common hierarchies of susceptibility to the induction of neural tube defects in mouse embryos by valproic acid and its 4-propyl-4-pentenoic acid metabolite. Teratology, 38, 313-320.
13. FINNEL, R. H., NAU, H. and YERBY, M. S. (1995) General principles: teratogenicity of antiepileptic drugs. In Antiepileptic Drugs, R. H. Levy, R. H. Mattson and B. S. Meldrum, eds (Raven Press, Ltd, New York), pp. 209-230.
14. FLINT, Y. B., LEVKOWITZ, G. and VARDIMON, L. (1994) Involvement of c-Jun in the control of glucocorticoid receptor transcriptional activity during development of chicken retinal tissue. European Molecular Biology Organization Journal, 13(3), 645-654.
15. FUNDER, J. W. (1993) Mineralocorticoids, glucocorticoids, receptors and response elements. Science, 259, 1132-1133.
16. FUXE, K, CINTRA, A., CHADI, G., GUSTAFSSON, J. A. and AGNATI, L. F. (1994) Central glucocorticoid receptors and neuronal plasticity. In Neurobiology of Steroids, Vol. 22, E. R. de Kloet and W. Sutanto, eds (Academic Press, New York), pp. 372-382.
17. GERMAN, J. (1984) Embryonic stress hypothesis of teratogenesis. American Journal of Medicine, 76, 293-301.
18. GIBSON, J. E. (1973) Teratology studies in mice with 2-sec-butyl-4,6-dinitrophenol (Dinoseb). Fundamentals in Cosmetic Toxicology, 11, 31-43.
19. GOODMAN, L. S. and GILMAN, A. (1993) Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 8th edition (McGraw-Hill, Inc., New York).
20. HOOD, R. D., VEDEL-MACRANDER, G. C., ZAWOROTKO, M. J., TATUM, F. M. and MEEKS, R. G. (1987) Distribution, metabolism, and fetal uptake of pentavalent arsenic in pregnant mice following oral or intraperitoneal administration. Teratology, 35, 19-25.
21. KALINYAK, J. E., DORIN, R. I., HOFFMAN, A. R. and PERLMAN, A. J. (1987) Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone. Journal of Biological Chemistry, 262(22), 10441-10444.
22. KAO, J., BROWN, N. A., SCHMIDT, B., GOULDING, E. H. and FABRO, S. (1981) Teratogenicity of valproic acid: In vivo and in vitro investigations. Teratogenesis, Carcinogenesis and Mutagenesis, 1, 367-382.
23. KEEN, C. L., TAUBENECK, M. W., DASTON, G. P., GERSHWIN, M. E., ANSARI, A. and TOGERS, J. M. (1995) Primary and secondary zinc deficiency as factors contributing to abnormal central nervous system development. Developmental Brain Dysfunction, 8, 78-89.
24. KRAFT, J. C., LOFBERG, B., CHAHOUD, I., BOCHERT, G. and NAU, H. (1989) Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice. Toxicology and Applied Pharmacology, 100, 162-176.
25. LAMMER, E. J. SEVER, L. E. and OAKLEY, G. P. (1987) Teratogen update: valproic acid. Teratology, 35, 465-473.
26. 2(E)-valproate in animals. Pharmaceutisch Weekblad Scientific, 14(3A), 139-143.
27. MACKLER, S. A., BENNETT, G. D., TSUEI, V. and FINNELL, R. H. (1996) Cocaine exposure selectivity alters levels of neurotransmitter receptor mRNAs in murine embryos. Reproductive Toxicology, 10, 37-42.
28. MAST, T. J., CUKIERSKI, M. A., NAU, H. and HENDRICKX, A. G. (1986) Predicting the human teratogenic potential of the anticonvulsant, valproic acid, from a non-human primate model. Toxicology, 39, 111-119.
29. MIESFELD, R., RUSCONI, S., GODOWSKI, P. J., MALER, B. A., OKRET, P. J., WILKSTROM, A. C., GUSTAFSSON, J. and YAMAMOTO, K. R. (1986) Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell, 46(3), 389-399.
30. MIYASHIRO, K., FINNELL, R. H., OUYANG, A., SPENCER, C. M., MACKLER, S. A. and EBERWINE, J. H. (1993) In situ transcription: methodology and multifaceted applications. In In Situ Hybridization: Applications to Neurobiology, Vol. II, J. H. Eberwine, K. Valentino and J. Barchas, eds (Cold Spring Harbor Press, Cold Spring Harbor, New York).
31. MORRISSEY, R. E. and MOTTET, N. K. (1983) Arsenic-induced exencephaly in the mouse and associated lesions occurring during neurulation. Teratology, 28, 399-411.
32. MOTTET, N. K. and FERM, V. H. (1983) The congenital teratogenicity and perinatal toxicity of metals. In Reproduction and Developmental Toxicity of Metals, T. W. Clarkson, G. F. Nordberg and P. R. Sager, eds (Plenum Press, New York).
33. NAU, H. (1985) Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional regimen in the mouse. Toxicology and Applied Pharmacology, 80, 243-250.
34. NAU, H. (1994) Valproic acid-induced neural tube defects. Neural Tube Defects. Ciba Foundation Symposium 181 (Wiley, Chichester), pp. 144-160.
35. NAU, H. and LOSCHER, W. (1986) Pharmocologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice. Fundamental and Applied Toxicology, 6, 669-676.
36. ONG, L. I., SCHARDEIN, J. L., PETRERE, J. A., SAKOWSKI, R., JORDAN, H., HUMPHREY, R., FITZGERALD, J. E. and IGLESIA, F. A. (1983) Teratogenesis of calcium valproate in rats. Fundamental and Applied Toxicology, 3, 121-126.
37. PADMANABHAN, R. and HAMEED, M. S. (1994) Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse. Journal of Craniofacial Genetics Developmental Biology, 14, 192-205.
38. PEARCE, D. and YAMAMOTO, K. R. (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science, 259, 1161-1164.
39. ROBERT, E. (1982) Valproic acid in pregnancy - association with spina bifida: a preliminary report. Clinical Pediatrics, 22(5), 336.
40. ROSA, F. W., WILK, A. L. and KELSEY, F. O. (1986) Teratogen update: vitamin A congeners. Teratology, 33, 355-364.
41. SAS INSTITUTE (1990) SAS/STAT User's Guide, Volumes I and II (SAS Institute, Inc., North Carolina).
42. SATO, M., SHIROTA, M. and NAGAO, T. (1995) Pantotnenic acid decreases valproic acid-induced neural tube defects in mice (I). Teratology, 52, 143-148.
43. SCHUMACHER, H. J. (1975) Chemicals structure and teratogenic properties. In Methods for Detection of Environmental Agents that Produce Congenital Defects, T. H. Shepard, J. R. Miller and M. Marois, eds (North-Holland, Amsterdam), pp. 65-77.
44. SHALET, S. L., WALKER, D. R. and FINNELL, R. H. (1996) The role of arsenic as a reproductive toxin with particular attention to neural tube defects. Journal of Toxicology and Environmental Health, 48, 101-120.
45. SHEPARD, T. H. (1992) Catalog of Teratogenic Agents, 7th edition (Johns Hopkins University Press, Baltimore).
46. SONADA, T., OHDO, S., OHBA, K. I., OKISHIMA, T. and HAYAKAWA, K. (1993) Sodium valproate-induced cardiovascular abnormalities in the Jcl:ICR mouse fetus: peak sensitivity of gestational day and dose-dependent effect. Teratology, 48, 127-132.
47. SVEC, F. (1985) Glucocorticoid receptor regulation. Life Sciences, 36, 2369-2366.
48. TAYLOR, L. E., BENNETT, G. D. and FINNELL, R. H. (1995) Altered gene expression in murine branchial arches following in utero exposure to retinoid acid. Journal of Craniofacial Genetics and Developmental Biology, 15, 13-25.
49. THEODOSIS, D. T. and FRASER, F. C. (1978) Early changes in the mouse neuroepithelium preceding exencephaly induced by hypervitaminosis. Teratology, 18, 219-232.
50. TSENG, W. P. (1977) Effects and dose response relationships of skin cancer and blackfoot disease with arsenic. Environmental Health Perspectives, 19, 109-119.
51. VARDIMON, L., DROR, B. I., HAVAZELET, N. and FOX, L. E. (1993) Molecular control of glutamine synthetase expression in the developing retina tissue. Developmental Dynamics, 196, 276-282.
52. WEINBERG, R. (1985) The action of oncogenes in the cytoplasm and nucleus. Science, 230, 770-778.
53. WHILLHITE, C. C. and FERM, V. H. (1984) Prenatal and developmental toxicology of arsenicals. Advances in Experimental Medical Biology, 177, 205-228.
54. WHITTLE, B. A. (1976) Preclinical, teratological studies on sodium valproate and other anticonvulsants. In Clinical and Pharmacological Aspects of Sodium Valproate (Epilim) in the Treatment of Epilepsy, N. Legg, ed. (MCS Consultants, Tunbridge Wells, UK), pp. 105-110.
55. ZIMMERMAN, E. F. (1975) Chemical structure and teratogenic mechanism of action. In Methods for Detection of Environmental Agents that Produce Congenital Defects, T. H. Shepard, J. R. Miller and M. Marois, eds (North-Holland, Amsterdam), pp. 79-88.